Bitget App
Trade smarter
Acheter des cryptosMarchésTradingFuturesEarnCommunautéPlus

DRMA stock price forecast

How will DRMA stock perform in 2026 and 2030?

This page primarily displays the projected price range for DRMA stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of DRMA, the development trends of Dermata Therapeutics, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for DRMA. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Dermata Therapeutics, Inc.'s financial performance and industry trends to provide short-term price predictions for DRMA stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year DRMA stock price forecast

Price target:
3.71 USD
+187.60%
Based on 1-year price forecasts from 37 analysts, the highest estimate is 5.51 USD, while the lowest estimate is 1.62 USD.

Analyst rating for DRMA

Based on ratings from 30 analysts over the past three months, the overall consensus is Buy.

Strong buy
9
Buy
10
Hold
7
Sell
3
Strong sell
1

FAQ

How has DRMA's EPS performed recently?

DRMA's EPS is projected to reach -- USD next quarter. Explore more Dermata Therapeutics, Inc. financial data and stay up to date on the company's latest developments on the DRMA stock details page.

What is the revenue forecast for DRMA next quarter?

Dermata Therapeutics, Inc.'s revenue is projected to reach -- USD in the next quarter. You can view Dermata Therapeutics, Inc.'s revenue and earnings on the DRMA stock details page.

What is the price target for DRMA?

Based on analyst estimates, the most likely target price for DRMA over the next 12 months is 3.71 USD, with a projected high of 5.51 USD and a projected low of 1.62 USD. To track whether this target is reached within the next year, you can view the DRMA stock price chart on the DRMA stock details page to check the current DRMA stock price, or follow the latest developments related to DRMA on the DRMA Stock News page.

What is the analyst rating for DRMA?

We collected ratings from 30 analysts who have evaluated DRMA stock over the past three months. Most analysts maintain a Buy outlook, and after aggregating all opinions, the overall consensus rating is Buy. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of DRMA stock in 2030?

Based on price forecasts and analyses of Dermata Therapeutics, Inc. from Wall Street analysts and major investment banks, DRMA is projected to trade between 2.58 USD and 12.90 USD in 2030.

DRMA stock chart

DRMA stock details

Variation du cours des actions DRMA

Le dernier jour de trading, l'action DRMA a clôturé à 1.29 USD, avec une variation de prix de -4.44% pour la journée.

Trader des Futures sur actions

À propos de Bitget

La première plateforme d'échange (UEX) au monde, permettant aux utilisateurs de trader non seulement des cryptomonnaies, mais aussi des actions, des ETF, le Forex, l'or et des actifs du monde réel (RWA).
En savoir plus
NASDAQ/
DRMA stock price forecast
Bitget© 2026